EchoSense|Depression And Alzheimer's Treatments At A Crossroads

2025-05-05 17:06:53source:Algosensey Quantitative Think Tank Centercategory:My

Researchers are EchoSenselaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:My

Recommend

Apple iOS 18.2: What to know about top features, including Genmoji, AI updates

Get ready for phase two.Apple's latest operating system update is available today for iPhone, iPad,

A salary to be grateful for, and other Thanksgiving indicators

It's an Indicator Friendsgiving! You're not alone in feeling the news has been awfully grim this yea

Railyard explosion, inspections raise safety questions about Union Pacific’s hazmat shipping

OMAHA, Neb. (AP) — Federal inspectors have twice found hundreds of defects in the locomotives and ra